Related Experiment Videos
'Anesthesia paresthetica': nitrous oxide-induced cobalamin deficiency
1Neuromuscular Center, Mt. Sinai Medical Center, Cleveland, OH 44106, USA.
Neurology
|August 1, 1995
Summary
Subclinical cobalamin deficiency can lead to severe neurological symptoms like ataxia and vertigo after nitrous oxide exposure. Early recognition is crucial for patients undergoing procedures involving this anesthetic.
Area of Science:
- Neurology
- Biochemistry
Background:
- Cobalamin (vitamin B12) is essential for neurological function.
- Nitrous oxide inactivates cobalamin-dependent enzymes, including methionine synthase.
Observation:
- A patient with undiagnosed cobalamin deficiency experienced syncope, vertigo, paresthesias, and ataxia.
- These symptoms emerged after two exposures to nitrous oxide anesthesia.
Findings:
- Subclinical cobalamin deficiency significantly increases susceptibility to nitrous oxide's neurotoxic effects.
- Nitrous oxide exposure can precipitate myeloneuropathy in deficient individuals.
Implications:
- Clinicians must consider cobalamin deficiency in patients presenting with neuropathic symptoms post-procedure.
- Screening for cobalamin deficiency may be warranted before procedures involving nitrous oxide.
- Awareness can prevent severe neurological complications and improve patient outcomes.